Skip to main content
. 2021 Aug 17;7(8):e07818. doi: 10.1016/j.heliyon.2021.e07818

Table 4.

Distribution of comorbidities presented by patients.

Age Gender 2020
2021
Comorbidity (n)
Comorbidity (n)
None dm htn asthma DVT/PE Ca None dm htn asthma DVT/PE Ca
<20 Male - - - - - - 1 - - - - -
Female 1 - - - - - 1 - - - - -
20–29 Male - - - - - - 1 - - - - -
Female 2 - - - - - 1 - - - - -
30–39 Male 3 - - - - - 3 - 1 - - -
Female 4 - - - - - 2 - 1 - - 2
40–49 Male 7 - - - - - 10 1 1 - - -
Female 5 - - - - - 1 - - - 1 -
50–59 Male 5 1 1 - - 1 3 - - - - -
Female 1 - - - - - 3 - - - - -
60–69 Male 7 2 1 1 - - 8 1 1 - - -
Female 5 - - - - - 1 - - - - -
70–79 Male 3 - - - - - 2 - - - - -
Female 1 - - - - - 2 - 0 - 1 -
80–89
Male 1 - - - 1 - 1 - - - - -
Female 0 - - - - - 1 - - - - -

Total 45 3 2 1 1 1 43 2 4 0 2 2

Key: dm = diabetes; htn = hypertension; DVT/PE = deep vein thrombosis/pulmonary embolism; Ca= Cancer.